Arranz Martín Alfonso, Calle Pascual Alfonso, Del Cañizo Gómez Francisco Javier, González Albarrán Olga, Lisbona Gil Arturo, Botella Serrano Marta, Pallardo Sánchez Luis Felipe
Servicio de Endocrinología y Nutrición, Hospital Universitario de la Princesa, Madrid, España.
Servicio de Endocrinología y Nutrición, Hospital Universitario Clínico de San Carlos, Madrid, España.
Endocrinol Nutr. 2015 Apr;62(4):171-9. doi: 10.1016/j.endonu.2015.01.003. Epub 2015 Feb 26.
To analyze the available information about continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems in the public health care system of the Community of Madrid.
A survey consisting of 31 items was sent to the 28 endocrinology department of the Madrid public hospitals. Items focused on CSII and CGM and included patients' registrations, as well as data regarding healthcare, administrative, and logistic aspects. Responses from a total of 20 hospitals where these procedures are used were received from March 2013 to May 2014. Data about pediatric patients were obtained from adult endocrinology departments, except for two hospitals which directly reported the information.
A total of 1256 CSII pumps were recorded in the Madrid region, of which 1089 were used by adults, and the remaining 167 by pediatric patients. During 2013, 151 new CSII systems were implanted (12% of the total), while 14 pumps were withdrawn. Availability of human resources (medical assistance) and the number of staff practitioners experienced in management of these systems widely varied between hospitals. Eighty-five percent of hospitals used retrospective CGM systems, and 40% routinely placed them before starting an insulin pump. Thirteen hospitals (65%) used long-term, real-time CGM systems in selected cases (a total of 67 patients).
Use of these technologies in diabetes is unequal between public health care hospitals in Madrid, and is still significantly lower as compared to other countries with similar incomes. However, there appears to be a trend to an increase in their use.
分析马德里自治区公共卫生保健系统中持续皮下胰岛素输注（CSII）和持续葡萄糖监测（CGM）系统的现有信息。
向马德里公立医院的28个内分泌科发送了一份包含31项内容的调查问卷。调查项目聚焦于CSII和CGM，包括患者登记情况以及医疗、行政和后勤方面的数据。2013年3月至2014年5月期间，共收到了20家使用这些程序的医院的回复。儿科患者的数据从成人内分泌科获取，只有两家医院直接报告了相关信息。
马德里地区共记录了1256台CSII泵，其中1089台供成人使用，其余167台供儿科患者使用。2013年期间，植入了151套新的CSII系统（占总数的12%），同时有14台泵被撤回。各医院在人力资源（医疗援助）的可用性以及管理这些系统的有经验的工作人员数量方面差异很大。85%的医院使用回顾性CGM系统，40%的医院在启动胰岛素泵之前常规使用该系统。13家医院（65%）在特定病例中使用长期实时CGM系统（共67例患者）。
马德里公共卫生保健医院之间在糖尿病治疗中对这些技术的使用情况不均衡，与其他收入水平相似的国家相比，使用率仍然显著较低。然而，其使用似乎有增加的趋势。
